Literature DB >> 22983898

Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections.

Staci Kearney1, Christine Delgado, Laurel L Lenz.   

Abstract

The type I and II interferons (IFNs) play important roles in regulating immune responses during viral and bacterial infections and in the context of autoimmune and neoplastic diseases. These two IFN types bind to distinct cell surface receptors that are expressed by nearly all cells to trigger signal transduction events and elicit diverse cellular responses. In some cases, type I and II IFNs trigger similar cellular responses, while in other cases, the IFNs have unique or antagonistic effects on host cells. Negative regulators of IFN signaling also modulate cellular responses to the IFNs and play important roles in maintaining immunological homeostasis. In this review, we provide an overview of how IFNs stimulate cellular responses. We discuss the disparate effects of type I and II IFNs on host resistance to certain intracellular bacterial infections and provide an overview of models that have been proposed to account for these disparate effects. Mechanisms of antagonistic cross talk between type I and II IFNs are also introduced.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22983898      PMCID: PMC3926967          DOI: 10.1007/s12026-012-8362-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  148 in total

1.  Expression of the p60 autolysin enhances NK cell activation and is required for listeria monocytogenes expansion in IFN-gamma-responsive mice.

Authors:  Jessica Humann; Ryan Bjordahl; Karl Andreasen; Laurel L Lenz
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 2.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

3.  Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.

Authors:  Julie Claudinon; Pauline Gonnord; Emilie Beslard; Marta Marchetti; Keith Mitchell; Cédric Boularan; Ludger Johannes; Pierre Eid; Christophe Lamaze
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections.

Authors:  Manira Rayamajhi; Jessica Humann; Staci Kearney; Krista K Hill; Laurel L Lenz
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

6.  Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1.

Authors:  A Muhlethaler-Mottet; W Di Berardino; L A Otten; B Mach
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

7.  p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons.

Authors:  K C Goh; S J Haque; B R Williams
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

8.  Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.

Authors:  Katrin Breitbach; Sonja Klocke; Thomas Tschernig; Nico van Rooijen; Ulrich Baumann; Ivo Steinmetz
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

9.  Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens.

Authors:  Zijiang Zhao; Blima Fux; Megan Goodwin; Ildiko R Dunay; David Strong; Brian C Miller; Ken Cadwell; Monica A Delgado; Marisa Ponpuak; Karen G Green; Robert E Schmidt; Noboru Mizushima; Vojo Deretic; L David Sibley; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2008-11-13       Impact factor: 21.023

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  14 in total

1.  Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis.

Authors:  Hideo Negishi; Kosuke Matsuki; Nobuyasu Endo; Hana Sarashina; Shoji Miki; Atsushi Matsuda; Keiko Fukazawa; Naoko Taguchi-Atarashi; Hiroaki Ikushima; Hideyuki Yanai; Junko Nishio; Kenya Honda; Yoichiro Fujioka; Yusuke Ohba; Tetsuo Noda; Shun'ichiro Taniguchi; Eisuke Nishida; Yongliang Zhang; Hongbo Chi; Richard A Flavell; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

Review 2.  Cytokine and lipid mediator networks in tuberculosis.

Authors:  Katrin D Mayer-Barber; Alan Sher
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

3.  IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.

Authors:  Karolina Maciag; Raktima Raychowdhury; Karen Smith; Alexis M Schneider; Jörn Coers; Maxwell R Mumbach; Schraga Schwartz; Nir Hacohen
Journal:  J Leukoc Biol       Date:  2021-11-26       Impact factor: 6.011

4.  Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription.

Authors:  Staci J Kearney; Christine Delgado; Emily M Eshleman; Krista K Hill; Brian P O'Connor; Laurel L Lenz
Journal:  J Immunol       Date:  2013-08-09       Impact factor: 5.422

Review 5.  The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; D Lorne Tyrrell; Michael Houghton
Journal:  Emerg Microbes Infect       Date:  2014-07-16       Impact factor: 7.163

6.  Using IFN-γ antibodies to identify the pathogens of fungal rhinosinusitis: A novel immunohistochemical approach.

Authors:  Yuyan Yan; Zuotao Zhao; Gehong Dong; Yiding Han; Dongmei Yang; Hongyan Yin; Yingshi Piao; Chunyan He; Cheng Tian; Hongfei Wan; Xue Li; Yulan Jin; Jugao Fang; Honggang Liu
Journal:  Mol Med Rep       Date:  2017-12-27       Impact factor: 2.952

7.  Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection.

Authors:  Emily M Eshleman; Christine Delgado; Staci J Kearney; Rachel S Friedman; Laurel L Lenz
Journal:  PLoS Pathog       Date:  2017-05-22       Impact factor: 6.823

Review 8.  The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.

Authors:  Janina Bruening; Bettina Weigel; Gisa Gerold
Journal:  J Immunol Res       Date:  2017-02-01       Impact factor: 4.818

9.  Oral Administration of Lactococcus lactis Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout.

Authors:  Alvaro Santibañez; Diego Paine; Mick Parra; Carlos Muñoz; Natalia Valdes; Claudia Zapata; Rodrigo Vargas; Alex Gonzalez; Mario Tello
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 10.  Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.

Authors:  Emily M Eshleman; Laurel L Lenz
Journal:  Front Immunol       Date:  2014-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.